Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and...
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
Several new studies show how exercise can extend cancer patients’ survival, reduce the risk of recurrence, and improve quality...
The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...